Going the Extra Mile: Why Clinical Research in Cystic Fibrosis Must Include Children
This is an exciting time for research and novel drug development in cystic fibrosis. However, rarely has the adage, “Children are not just little adults” been more relevant. This article is divided into two main sections. In the first, we explore why it is important to involve children in research....
Main Authors: | Rebecca Dobra, Siân Bentley, Claire Edmondson, Maxine Ovens, Clare Saunders, Christopher Short, Gemma Wilson, Jane C. Davies, Andrew Bush |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/9/7/1080 |
Similar Items
-
Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis
by: Andre Schultz, et al.
Published: (2019-03-01) -
Including random centre effects in design, analysis and presentation of multi-centre trials
by: Kate Edgar, et al.
Published: (2021-05-01) -
A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Eric WFW Alton, et al.
Published: (2016-07-01) -
Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
by: Lucy Perrem, et al.
Published: (2020-09-01) -
The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies
by: Kui Li, et al.
Published: (2022-10-01)